Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-21-011908
Filing Date
2021-06-09
Accepted
2021-06-09 21:39:00
Documents
2
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162328912152054.html 3  
1 FORM 3 wf-form3_162328912152054.xml 3 3411
2 SUBRA SANKAR POA ex-24.htm EX-24 2157
  Complete submission text file 0001628280-21-011908.txt   7046
Mailing Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address C/O NAUTILUS BIOTECHNOLOGY, INC. 201 INDUSTRIAL RD. #310 SAN CARLOS CA 94070
Business Address
Sankar Subramanian (Reporting) CIK: 0001856744 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39434 | Film No.: 211006708